HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher G Goetz Selected Research

sarizotan

4/2008Placebo influences on dyskinesia in Parkinson's disease.
1/2007Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
3/2004Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher G Goetz Research Topics

Disease

42Parkinson Disease (Parkinson's Disease)
01/2022 - 03/2002
14Dyskinesias (Dyskinesia)
01/2021 - 05/2000
8Hallucinations (Hallucination)
03/2014 - 08/2004
7Movement Disorders (Movement Disorder)
10/2021 - 05/2002
7Parkinsonian Disorders (Parkinsonism)
10/2019 - 05/2003
7Dementia (Dementias)
05/2012 - 01/2006
5Tremor (Tremors)
01/2022 - 06/2006
4Psychotic Disorders (Schizoaffective Disorder)
10/2011 - 12/2006
2Chronic Disease (Chronic Diseases)
01/2022 - 05/2010
2Fragile X Tremor Ataxia Syndrome
04/2020 - 01/2010
2Erectile Dysfunction
05/2017 - 10/2011
2Cognitive Dysfunction
01/2017 - 10/2008
2Disease Progression
12/2014 - 05/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
07/2012 - 02/2007
2Fatigue
10/2011 - 05/2010
2Alzheimer Disease (Alzheimer's Disease)
02/2007 - 12/2003
2Dystonia (Limb Dystonia)
10/2006 - 05/2000
2Hysteria
05/2004 - 04/2003
1Multiple System Atrophy
01/2022
1Synucleinopathies
01/2022
1Urolithiasis
02/2014
1Gout
02/2014
1Essential Tremor (Essential Tremors)
11/2013
1Atrophy
05/2012
1Constipation
10/2011
1Gambling (Pathological Gambling)
10/2011
1Disorders of Excessive Somnolence (Hypersomnia)
10/2011

Drug/Important Bio-Agent (IBA)

12Levodopa (L Dopa)FDA LinkGeneric
01/2022 - 03/2004
8Antipsychotic Agents (Antipsychotics)IBA
09/2011 - 02/2006
4Amantadine (Aman)FDA LinkGeneric
01/2017 - 07/2007
4Biomarkers (Surrogate Marker)IBA
05/2014 - 05/2003
4Clozapine (Clozaril)FDA LinkGeneric
10/2011 - 06/2009
3Uric Acid (Urate)IBA
01/2022 - 02/2014
3InosineFDA Link
01/2022 - 02/2014
3Pharmaceutical PreparationsIBA
01/2022 - 07/2007
3Dopamine (Intropin)FDA LinkGeneric
01/2017 - 01/2010
3Dopamine Agents (Dopaminergic Agents)IBA
08/2010 - 01/2007
3sarizotanIBA
04/2008 - 03/2004
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022 - 01/2021
2Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 10/2011
2Memantine (Namenda)FDA Link
04/2020 - 10/2011
2Sildenafil Citrate (Viagra)FDA Link
05/2017 - 10/2011
2salicylhydroxamic acid (SHAM)IBA
08/2015 - 07/2012
2Pergolide (Permax)FDA Link
10/2011 - 10/2011
2Pramipexole (Mirapex)FDA LinkGeneric
10/2011 - 10/2011
2Cholinergic Antagonists (Anticholinergics)IBA
09/2011 - 01/2006
2Cholecystokinin (Pancreozymin)IBA
08/2011 - 08/2004
2Messenger RNA (mRNA)IBA
01/2010 - 01/2007
2Opioid Analgesics (Opioids)IBA
08/2008 - 07/2007
2Selegiline (E250)FDA LinkGeneric
05/2005 - 03/2002
1Butyric Acid (Butanoic Acid)IBA
01/2022
1Succinic Acid (Succinate)IBA
01/2022
1Glucosylceramidase (Glucocerebrosidase)IBA
01/2022
1Lactic Acid (Lactate)FDA LinkGeneric
01/2022
1trimethyloxamine (trimethylamine N-oxide)IBA
01/2022
1Volatile Fatty AcidsIBA
01/2022
1Isradipine (Dynacirc)FDA LinkGeneric
10/2021
1Hormones (Hormone)IBA
01/2021
1IncretinsIBA
01/2021
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2021
1Neuroprotective AgentsIBA
01/2021
1AntioxidantsIBA
10/2019
1Topiramate (Topamax)FDA LinkGeneric
01/2017
16- fluoro- 2- (4- (pyridin- 2- yl)but- 3- yn- 1- yl)imidazo(1,2- a)pyridineIBA
01/2016
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2016
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2016
1NeurturinIBA
08/2015
1Biological ProductsIBA
02/2014
1CitalopramFDA LinkGeneric
10/2011
1batrachotoxinin A 20-alpha-benzoateIBA
10/2011
1ropinirole (Requip)FDA LinkGeneric
10/2011
1nefazodone (Serzone)FDA LinkGeneric
10/2011
1Rivastigmine (Exelon)FDA LinkGeneric
10/2011
1Quetiapine Fumarate (Seroquel)FDA Link
10/2011
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
10/2011
1Eszopiclone (Lunesta)FDA Link
10/2011
1Olanzapine (Zyprexa)FDA Link
10/2011
1Donepezil (Aricept)FDA LinkGeneric
10/2011
1Modafinil (Provigil)FDA Link
10/2011
1CabergolineFDA LinkGeneric
10/2011
1Amitriptyline (Elavil)FDA LinkGeneric
10/2011
1Antidepressive Agents (Antidepressants)IBA
10/2011
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
10/2011
1Carbidopa (Lodosyn)FDA LinkGeneric
10/2011
1Desipramine (Pertofrane)FDA LinkGeneric
10/2011
1Domperidone (Domperidon)IBA
10/2011
1FludrocortisoneIBA
10/2011
1Fluoxetine (Prozac)FDA LinkGeneric
10/2011
1Galantamine (Galanthamine)FDA LinkGeneric
10/2011
1Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
10/2011

Therapy/Procedure

15Therapeutics
01/2021 - 05/2002
7Activities of Daily Living (ADL)
01/2017 - 10/2008
5Deep Brain Stimulation
01/2022 - 12/2015
2Drug Therapy (Chemotherapy)
01/2022 - 01/2022
2Transplantation
02/2009 - 09/2003
2Hypnosis (Mesmerism)
05/2004 - 04/2003
1Aftercare (After-Treatment)
01/2019
1PD protocol
12/2015
1Neurosurgical Procedures
07/2012
1Tai Ji (Tai Chi Chuan)
01/2012